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Abstract With so many disciplines of both medicine and dentistry
involved in the treatment of obstructive sleep apnea (OSA), several
forms of therapy are available. The orthodontist is rarely considered
when the diagnosis of chronic obstructive sleep apnea (OSA) is deliv-
ered. However, the scope of orthodontic care today is much broader
than the mere alignment of teeth. While the current gold standard for
OSA care remains continuous positive air pressure (CPAP), the patient
may be given a prescription for an intra-oral sleep appliance. When
orthodontists work in concert with their medical colleagues to provide
a sleep appliance, several considerations must be made including the
evidence regarding oral appliance efficacy. For some patients, oral
appliances are highly successful; however, even for responsive
patients, there are risks associated with oral appliance
therapy. The aim of the paper was to present a critical review of the
current level of evidence for the use of oral appliances in the treatment
of OSA. A substantial number of publications ranging from case
reports, uncontrolled and controlled case series, prospective random-
ized studies, and even a small number of systematic reviews were
available. The existing systematic reviews were based on either a lim-
ited number of prospective studies with limited numbers of patients or
in some cases were based on subjective data only. As a result, a nar-
rative review of the literature was performed that discusses objective
clinically testable criteria and recent developments that may aid future
research investigations.
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Introduction
Chronic obstructive sleep apnea (OSA) is a severe debilitating
disorder affecting people of all ages characterized by periodic
breathing cessation (apnea) or airflow reduction (hypopnea).
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Overweight middle-aged adult men have the
highest prevalence of the disease (1), yet women
and an increasing number of children are also
affected by OSA (2, 3). Several disciplines within
dentistry are well equipped to provide successful
treatment for patients with OSA due to their
knowledge of facial growth and development
and background in craniofacial and dentofacial
anomalies. Patients who may not routinely see
their physician may be unaware of their condi-
tion (4), and an observant dentist or dental spe-
cialist may pick up signs and symptoms of OSA
during the dental visit, enabling them to make
an appropriate referral to the physician and/or
sleep team for definitive diagnosis. Once prop-
erly diagnosed, several treatment modalities are
available (5–9) that lead to successful improve-
ment in both the patient’s subjective and objec-
tive assessment of their daytime sleepiness (10–
13). The dental professional can provide some of
the most highly successful treatments and pro-
vide a life-saving service and health benefit
beyond improvement of the patients smile and
self-esteem.
This study will present a critical review of the
current evidence for the use of oral appliances
in the treatment of OSA. A substantial number
of publications are available, but the existing
systematic reviews are based on either a limited
number of prospective studies with limited
numbers of patients or in some cases on subjec-
tive criteria. As a result, this critical review will
discuss objective clinically testable criteria and
recent developments that may aid future
research investigations.
Diagnosis and classification of adult
obstructive sleep apnea
The classic symptom of OSA is excessive day-
time sleepiness, and the Epworth Sleepiness
Scale (14) is an easy, inexpensive screening
tool that assesses the patient’s relative sleep
health. Unfortunately, the test is extremely lim-
ited and is not able to distinguish OSA from
the many other types of sleep-disordered
breathing such as central sleep apnea, restless
leg syndrome, narcolepsy, and many other
conditions.
The gold standard for proper diagnosis of
obstructive sleep apnea is an overnight poly-
somnography (PSG)(15) which combines the
results of electroencephalogram (EEG), electro-
cardiogram (EKG), electrooculogram (EOG), and
electromyography (EMG) along with respiration
rate, tidal volume, inspiration and expiration
volumes, resulting in the patient’s apnea–
hypopnea index (AHI). An apnea is defined as
a cessation in breathing for 10 s or more with
an arterial oxygen desaturation of two to four
percent (16). A hypopnea is defined as a fifty
percent decrease in airflow for 10 s or more
with a concomitant drop in arterial oxygen
saturation (16).
Patients with normal sleep have an AHI of 5 or
less events per hour of sleep, mild sleep apnea
patients have an AHI 5–15, moderate sleep
apnea patients have an AHI 15–30 and severe
sleep apnea patients have an AHI over 30 events
per hour (16). To more critically assess severity,
the AHI is subdivided into an apnea index (AI), a
hypopnea index (HI), and respiratory event-
related arousals (RERA). The subdivision of
apnea alone and hypopnea alone helps refine
the severity classification because patients with
primarily apnea are more severely affected than
patients with predominantly hypopneas. The dif-
ference may result in dramatically different
treatment approaches. To further illustrate the
biological impact of obstructive sleep apnea, one
must understand that a patient with an AHI of
60 stops breathing or has a significant oxygen
desaturation for at least 10 s every minute. The
cumulative effect leads to significant reduction
in oxygen perfusion to the brain causing an
increased risk of stroke, myocardial infarction,
and other cardiac anomalies (17). Central apnea
is distinguished from obstructive apnea due
to the lack of respiratory effort (documented
by EMG) (18). This distinction is essential
because treatment by the dental professional is
mechanical and only effective for obstructive
apnea.
The guidelines for what constitutes successful
treatment vary widely, with the most stringent
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criteria for success including achieving an AHI
of less than 5. More conservative success criteria
attempt to achieve ≥50% reduction in the AHI or
an AHI of less than 10. A recent report states
that successfully treated patients have no
increased morbidity or mortality (19), while
untreated individuals have a 37% higher 5-year
morbidity and mortality (12) resulting from
higher incidence of heart attack, stroke, arrhyth-
mia, hypertension, and motor vehicle accidents,
with one study concluding that the incidence of
motor vehicle accidents associated with obstruc-
tive sleep apnea is comparable to driving while
intoxicated (20, 21).
Treatment modalities
The American Association of Sleep Medicine
(AASM) describes continuous positive air pres-
sure (CPAP) as the gold standard. The AASM
also describes eight surgical treatment options
and five conservative treatment options for the
patient with OSA. The general surgical proce-
dures most commonly include bariatric surgery
(22) to assist with significant weight loss and
pharyngeal surgery to remove adenotonsillar
hypertrophy and/or to reduce the size of the
uvula (23). The dental surgical procedures
include genioplasty, mandibular advancement,
and maxillomandibular advancement (MMA).
Oral appliance therapy is among the conserva-
tive treatment options listed.
Oral appliance therapy rationale
The theoretical basis for the potential treatment
effect is that in the supine position, all gravity-
dependent tissue tends to fall posteriorly, includ-
ing the tongue and lower jaw. If the oral appli-
ance can prevent one or both, the airway will
remain patent reducing the number of apneic
and hypopneic events.
The first but smallest class of oral appliance is
tongue-stabilizing appliances (Fig. 1). Normally,
the tongue base is held anteriorly by muscles
attached to the genial tubercles, but in the sleep-
ing patient, this support may be insufficient
resulting in airway occlusion. After measuring
the tongue perimeter with a piece of dental floss,
the appropriate size is selected, the appliance
bulb is moistened and compressed, and the ton-
gue is inserted. The negative pressure and the
salivary adhesion act synergistically to maintain
the tongue in a more forward position opening
the oropharyngeal airway. The appliance comes
in four sizes (S, M, L, and XL) and two versions
(dentate and non-dentate).
A second class of appliances actively protrudes
the mandible and maintains this forward posi-
tion during sleep (Fig. 2A and B). Several types
of appliances are available including the Kleer-
way (24) developed by orthodontists, and the
Tap (25) developed by a prosthodontist and
many others. Each is removable and allows the
patient to insert at night and remove upon wak-
A B
Fig. 1. Tongue-stabilizing appli-
ance A: sagittal view and B: fron-
tal view. The interior of the bulb
is moistened with water, the bulb
compressed, and then tongue
inserted. The negative pressure
created by compressing the bulb
maintains the tongue in a more
forward position.
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ing. The oral appliances are small, transportable,
and relatively inexpensive and reversible; that is,
there are no permanent dental changes in the
short-term if treatment is unsuccessful. Selection
of the specific advancing appliance can be made
using multiple factors including cost, conve-
nience, durability, adjustability, and patient
comfort giving the patient the freedom to indi-
vidually select the appliance, potentially aiding
compliance.
Oral appliance fabrication and
treatment
Prior to appliance fabrication, records should be
taken to document the patient’s oral health sta-
tus. The records should minimally consist of
photographs, dental casts, and on a case-by-case
basis, appropriate imaging (including lateral
cephalometric, panoramic radiograph, periapi-
cals, or cone beam computed tomography
(CBCT)). For some, the oral health and particu-
larly periodontal status will be poor resulting in
recommendation not to proceed. For others, the
records will serve as a baseline indicator for
assessment of dental or skeletal changes.
To fabricate, upper and lower dental impres-
sions and pre-treatment range of motion
including maximum opening, lateral excursions,
and maximum protrusion are obtained. The
appliance is constructed approximately one-half
to two-thirds of the patient’s maximum protru-
sion and several millimeters open. A George
gauge (Fig. 3) can be helpful in stabilizing the
patient in the construction bite position. The
impressions and bite registrations are then sent
to a commercial laboratory for fabrication or
made in-house. At delivery, appliance fit and
comfort are assessed and titrated to meet the
patient’s specific needs.
Efficacy
Dental practitioners who provide treatment for
OSA must be in compliance with the AASM
treatment parameters for oral appliances, first
established in 1995 (26). The best evidence avail-
able at that time was a limited number of case
series investigations. Since then, higher levels of
evidence including prospective randomized
clinical trials have become available resulting in
the 2005 AASM revised practice parameters (27).
The AASM’s strongest parameter is a practice
standard, established only after well-designed
prospective randomized clinical studies demon-
strate that treatment is beneficial and safe.
A
B
Fig. 2. A: Kleerway appliance
developed by orthodontist Dr.
Lowe and B: TAP appliance devel-
oped by Dr. Thornton. Both fit
intimately against the maxillary
and mandibular dental arches.
Each uses a screw type design to
titrate the final advanced mandib-
ular position for maximum treat-
ment effect.
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Practice guidelines are developed from lower lev-
els of evidence such as case series or prospective
studies with high potential bias and practice
parameters list treatment options with minimal
literature support. The underlying goal of estab-
lishing practice guidelines and parameters was
to highlight the current evidence and illustrate
the necessary future research directions required
for improved outcomes (28).
Given the significant morbidity and mortality
associated with unresolved OSA, it is essential to
quantify the treatment effect following oral
appliance delivery. Surveys and other subjective
measures nearly universally report positive
changes (29). Other indirect forms of assessment
include either two-dimensional lateral cephalo-
metric radiographs (30) or three-dimensional
imaging using cone beam computed tomogra-
phy (CBCT) to demonstrate airway size and
shape changes.
The gold standard assessment requires PSG,
and this has been performed in case reports,
case series, and prospective non-randomized
studies. Limited sample sizes, high dropout rate,
lack of controls, short study duration, and other
factors make interpretation and application of
these investigations difficult (31, 32).
More recently, higher levels of evidence using
PSG in prospective randomized control studies
have emerged. Okuno (33) demonstrated that
oral appliances improved AHI more than control
appliances, although less than CPAP. Contrary to
previous investigators (34, 35), their study group
demonstrated similar compliance rates with oral
appliances or CPAP. In a short-term prospective
randomized cross-over study (36), Phillips com-
pared the results of CPAP and a mandibular
advancing device (MAD). With over 100 patients
completing both arms of the study, the MAD
achieved complete resolution in 40% and partial
resolution in another 25% of patients in contrast
to CPAP which achieved complete resolution in
75% and partial in 15% of patients. Of note,
patients preferred the MAD over CPAP by a 2:1
margin and reported compliance was 6.5  1.3 h
for the MAD vs. 5.2  2 h per night for CPAP.
For long-term results, Ghazal compared two oral
appliances, a modified Herbst appliance (IST)
and a prosthodontic (TAP) appliance over several
years (25). The study utilized 103 consecutively
enrolled and randomly assigned middle-aged
adults. At 6 months, both appliances improved
the AHI, with the TAP having a higher percent-
age of success. By study end (42 months), both
appliance groups showed similar results. Caution
must be taken with these results as there was
significant patient drop out and loss to follow-up
leaving less than half the original study popula-
tion. Of note, this group was among the first to
examine not only the AHI, but also the effects of
oral appliances on blood pressure, an important
consideration given the recent concern that con-
trolling blood pressure (BP) may be more impor-
tant than AHI in reducing the adverse health
effects of OSA (37, 38).
With the increasing number or prospective
randomized studies, systematic reviews and
meta-analyses have now been performed exam-
A
B
Fig. 3. The George gauge is applied to the maxillary arch and
used to help the patient stabilize his/her mandible as they
protrude. A: sagittal view and B: occlusal view of the George
gauge. Many clinicians will use this ‘upside down’ placing the
mandibular incisors into the single slot and the maxillary inci-
sors into the slot that will provide a construction bite that is
50–60% of the patient’s maximum mandibular protrusion.
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ining different aspects of treatment. Using 14 of
a possible 1475 studies that met their initial
search criteria, Ahrens and Hagg evaluated oral
appliances (one or two piece) vs. control appli-
ances and each other (39). They concluded that
MAD appliances performed better than controls
with two-thirds of treated patient’s AHI improv-
ing. There was no difference between one-piece
MAD designs and also no difference for 50% or
75% maximum protrusion. Comparing one- or
two-piece design, there was no clearly superior
appliance. Using 7 separate studies with a
pooled 399 patients, Iftikhar evaluated oral
appliances and their effect on BP demonstrating
a modest decrease in systolic, diastolic, and
mean arterial pressure (40), although there was
no correlation between the reduced blood pres-
sure and the decreased AHI. Finally, Li per-
formed a systematic review using 14 prospective
randomized trials comparing the gold standard
CPAP with oral appliance therapy (41). The
results indicated CPAP was significantly more
effective in reducing AHI and AI and increasing
the minimum oxygen saturation (SpO2) than
oral appliances, and there was no compliance
difference between the two treatment
approaches. Their conclusion was that while
CPAP was better, oral appliances are appropriate
to prescribe to patients who are unable or
unwilling to wear CPAP.
Treatment limitations and side
effects
One must consider both the treatment limitations
(i.e., some patients do not respond to either
CPAP or OA) and potential side effects of any
prescribed treatment (42, 43). In addition with
oral appliances, concern arises regarding possible
dental changes (44, 45). In one study over a
seven-year period, 14.3% of oral appliance
patients showed no dental change, conversely
41.4% experienced favorable change, and 44.3%
experienced unfavorable bite changes. Favorable
change was described as patients with Class II
who improved; unfavorable change was observed
in Class I patients who became Class III. A more
recent two-year prospective randomized study
evaluated potential dental changes in both CPAP
and oral appliances. The oral appliance group
demonstrated a 1.1 mm decrease in overbite, a
1.5 mm decrease in overjet, and a reduced num-
ber of posterior contacts with CPAP demonstrat-
ing smaller occlusal changes (albeit smaller and
not statistically significant due to patient drop
out). CPAP also demonstrate a higher number of
moderate-to-severe side effects such as nasal
congestion, rhinorrhea, eye irritation, and sense
of suffocation that must be considered.
In an attempt to reduce dental side effects
through skeletal anchorage and to better treat
patients with excessive numbers of missing teeth,
a novel micro-implant retained device was
attempted in a small number (10) of patients
(46). All patient’s AHI improved over the 6-month
study period with 80% of TADs remaining stable,
and ‘no dental side effects were seen’ (46).
New developments
The data above indicates that oral appliances
completely resolve some, partially treat others,
with approximately one-third of users experienc-
ing no treatment effect. Using upright and alert
lung function tests of 35 patients, (25 responders
and 10 non-responders) Chan attempted to pre-
dict who would respond to oral appliance ther-
apy (47). The study group was able to correctly
assess patient’s 48.6% of the time, but with only
36% sensitivity. This failure led other investiga-
tors to perform remote-controlled activation of
a simulate oral appliance during a PSG prior to
prescribing one (48). The results are promising
but imperfect with a predictive accuracy of 83–
94%. Some subjects were anticipated to be
‘responders’ during the remote activation test
but did not experience a treatment effect from
oral appliance therapy and vice versa.
Conclusion
Oral appliance therapy has been investigated
and demonstrates one successful form of treat-
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ment that the dentist and dental specialist can
provide. CPAP remains the most effective form
of therapy, but may suffer from reduced patient
preference and compliance. While less effective
in reducing AHI, blood pressure, and increasing
SpO2, oral appliance therapy remains a viable
treatment options for patients unable to tolerate
or unwilling to wear CPAP. While the evidence
appears to be improving, additional stringent
long-term study methodology must be applied
to provide the highest levels of evidence in the
treatment of adult OSA.
Clinical relevance
The level of evidence in the treatment of
obstructive sleep apnea varies tremendously
ranging from clinical case reports to systematic
reviews and meta-analyses. With the ever-
increasing numbers of people affected by this
disease, it is essential to constantly review and
where needed add to the existing literature to
assure that people are treated with the most effi-
cacious intervention possible.
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